XML 102 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Cash Flows - BRL (R$)
R$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flow from operating activities      
Net income (loss) for the year R$ 319,814 R$ 1,820,994 R$ 1,677,815
Adjustment to      
Depreciation, depletion and amortization 1,563,223 1,402,778 1,403,518
(Income) loss from sale of property, plant and equipment and biological assets (4,523) (29,005) (9,767)
Equity in (earnings) loss of unconsolidated companies (7,576) (5,872) 7,127
Exchange and monetary variations, net 1,446,207 2,273 (1,442,918)
Interest expenses, net 789,670 877,313 1,000,287
Derivative gains (losses), net 2,735,196 (73,271) (528,839)
Fair value adjustment of biological assets 129,187 (192,504) 780,666
Deferred taxes (741,084) 236,431 530,072
Interest on employee benefits 35,920 38,022 36,856
Provision for contingencies 13,285 35,645 20,498
Share-based compensation plans 131,609 33,715 2,808
Allowance for doubtful accounts, net 6,450 32,397 17,005
Reversal of/(addition to) provision for discounts 27,681 (9,497) (35,497)
Provision for (reversal of) inventory losses and write-offs (34,560) 42,027 9,564
Write-off of tax credits   5,438  
Provision for losses (impairment) and write-off of property, plant and equipment and biological assets 18,103 66,707 316,646
Partial write-off of intangible assets   18,845 78,799
Other provisions 75,791 36,049 135,949
Decrease (increase) in assets      
Trade accounts receivables (186,026) (726,808) 212,908
Inventories (612,687) 100,119 (47,846)
Recoverable taxes 50,960 8,702 (39,689)
Other current and non-current assets (11,318) 415,345 (483,406)
Increase (decrease) in liabilities      
Trade accounts payable 1,473 63,236 (4,696)
Other current and non-current liabilities 192,566 (230,200) 1,204,144
Tax payable 567,868 864,315  
Payment of interest (806,758) (1,006,869) (1,102,090)
Other taxes and contributions paid (135,265) (598,617) (545,751)
Income taxes paid (327,282) (121,177) (90,532)
Actuarial liabilities (26,061) (21,595) (15,410)
Contingencies (41,013) (17,077) (12,682)
Net cash provided by operating activities 5,170,850 3,067,859 3,075,539
Cash flows from investing activities      
Additions to property, plant and equipment (1,251,486) (859,880) (885,999)
Additions to intangible assets (7,217) (8,054) (11,640)
Additions to biological assets (1,164,995) (912,368) (1,426,699)
Proceeds from sales of assets 95,481 84,694 35,235
Additions (reduction) in financial investments (19,340,022) 687,274 (1,053,381)
Acquisition of subsidiaries, net cash (294,473)    
Net cash used in investing activities (21,962,712) (1,008,334) (3,342,484)
Cash flow from financing activities      
Proceeds from loans and financing 20,964,722 2,561,954 5,665,635
Issue of Debentures 4,681,100    
Payment of derivative transactions (1,586,415) 39,695 117,261
Payment of loans and financings (3,738,577) (4,533,736) (4,853,038)
Payment of dividends (210,205) (570,568) (299,926)
Sale of treasury shares to meet share-based compensation plan 8,514 8,514 8,514
Liabilities for assets acquisitions (84,090) (117,865) (72,364)
Repurchase of treasury shares   (83)  
Net cash (used in) provided by financing activities 20,035,049 (2,612,089) 566,082
Exchange variation on cash and cash equivalents 67,433 14,700 (161,686)
Increase (reduction) in cash and cash equivalents 3,310,620 (537,864) 137,451
Cash and cash equivalents at the beginning of year 1,076,833 1,614,697 1,477,246
Cash and cash equivalents at end of year 4,387,453 1,076,833 1,614,697
Statement of the increase (reduction) in cash and cash equivalents R$ 3,310,620 R$ (537,864) R$ 137,451